Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q1 2025 Earnings Call Transcript May 7, 2025
Soleno Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.95, expectations were $-1.14.
Operator: Greetings, and welcome to the Soleno Therapeutics First Quarter 2025 Earnings Conference Call. At this time, note that all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder,...
